Skip to content
5.32 - ASH Update #1 - Talquetamab NEJM episode artwork

Dec 11, 2022 17 min

5.32 - ASH Update #1 - Talquetamab NEJM

from Plenary Session Hosted by Vinay Prasad MD MPH

Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.drvinayprasad.com/subscribe

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

5.32 - ASH Update #1 - Talquetamab NEJM

0:00 17:48

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Plenary Session?

This episode is 17 minutes long.

When was this Plenary Session episode published?

This episode was published on December 11, 2022.

Can I download this Plenary Session episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.